Bluefin Capital Management’s Medtronic MDT Stock Holding History

Bluefin Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,600	Closed	-$269K	–	850
2021 Q4	$269K	Sell	2,600 -1,175	-31%	-$136K	0.02%	482
2021 Q3	$473K	Buy	+3,775	New	+$489K	0.05%	286
2021 Q2	–	Sell	-6,285	Closed	-$742K	–	801
2021 Q1	$742K	Sell	6,285 -10,675	-63%	-$1.25M	0.03%	236
2020 Q4	$1.99M	Buy	+16,960	New	+$1.87M	0.12%	104
2020 Q1	–	Sell	-51,632	Closed	-$5.86M	–	574
2019 Q4	$5.86M	Buy	51,632 +49,731	+2,616%	+$5.46M	0.39%	72
2019 Q3	$206K	Sell	1,901 -2,631	-58%	-$275K	0.03%	275
2019 Q2	$441K	Buy	+4,532	New	+$414K	0.06%	157
2018 Q4	–	Sell	-6,554	Closed	-$645K	–	489
2018 Q3	$645K	Buy	+6,554	New	+$606K	0.06%	208
2016 Q1	–	Sell	-8,155	Closed	-$627K	–	634
2015 Q4	$627K	Buy	+8,155	New	+$614K	0.05%	280
2015 Q2	–	Sell	-4,614	Closed	-$360K	–	498
2015 Q1	$360K	Sell	4,614 -197,977	-98%	-$15M	0.03%	305
2014 Q4	$14.6M	Buy	202,591 +194,504	+2,405%	+$13.5M	0.88%	19
2014 Q3	$501K	Buy	8,087 +489	+6%	+$31.1K	0.03%	397
2014 Q2	$500K	Buy	+7,598	New	+$462K	0.02%	446

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.14B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bluefin Capital Management's MDT Position: Q1 2022 in Review

Bluefin Capital Management sold out of Medtronic (MDT) in Q1 2022, closing a stake of 2,600 shares — an estimated $269K sold.

Bluefin Capital Management first reported a position in MDT in Q2 2014 and held it in 13 quarters. The position peaked at $14.6M in Q4 2014. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

Bluefin Capital Management reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
Bluefin Capital Management sold 2,600 Medtronic shares in Q1 2022, an estimated $269K.
Bluefin Capital Management first reported a position in Medtronic in Q2 2014 and held it in 13 quarters.
Bluefin Capital Management's Medtronic position peaked at $14.6M in Q4 2014.
2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Bluefin Capital Management's 13F filing for Q1 2022, filed 16 May 2022.